Using in vivo mouse models, PRDM1/Blimp1 has been demonstrated to act as a tumor suppressor in activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL) [92, 93]. This evidence concerns the gene PRDM1 and diffuse large B-cell lymphoma.